Feb. 10 at 3:52 AM
$BCTX I asked AI co-pilot if BriaCell can share the phase 3 trial results with potential BP partners before it submitted to the FDA? Answer: Yes — BriaCell can share positive clinical data with a potential Big Pharma partner before submitting it to the FDA, but only under strict confidentiality and only if the data are fully locked, verified, and not selectively disclosed to the public.
This is standard practice in biotech partnering.
